|
|
||||||||
Clinical Chemistry, Vol 29, 31-36, Copyright © 1983 by American Association for Clinical Chemistry
DH Lo and TW Wu
Using unconjugated bilirubin (Bu) and authentic human disconjugated bilirubin (dBc) supplemented in low-bilirubin serum pools, we have directly verified for the first time that the Jendrassik-Grof total bilirubin assay modified after Doumas et al. (Clin. Chem. 19: 984-993, 1973) detects Bu and dBc quantitatively, in Bu-equivalent concentrations relative to gravimetric concentration assignment reinforced with quantification by nuclear magnetic resonance (Wu et al., Clin. Chem. 26: 1323-1335, 1980). By contrast, the Jendrassik-Grof direct bilirubin assay (also modified after Doumas) quantifies only 70 +/- 5% of the gravimetrically determined dBc as Bu equivalents. By using Bu and dBc (instead of Bu only, as is routinely done) to calibrate the responses of the total and direct bilirubin assays, the analyses of Bu and dBc become much more quantitative. We mathematically explored the meanings of the conventional terms total, direct, and indirect bilirubins. The clinical and diagnostic implications of our observations are discussed.
The following articles in journals at HighWire Press have cited this article:
![]() |
D. R. Dufour, J. A. Lott, F. S. Nolte, D. R. Gretch, R. S. Koff, and L. B. Seeff Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests Clin. Chem., December 1, 2000; 46(12): 2027 - 2049. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |